Request more info

EMEA: +44 (0) 1869 255758

US: +1 (800) 450 2403

Email: sales@thecompliancemap.com

Compliance Map now part of Source Intelligence – Find out more

News

Bevacizumab added to Proposition 65 List

13th Mar 2019

EMEA sales & customer support

+44 (0) 1869 255758

US sales & customer support

+1 (800) 450 2403

Email sales & customer support

sales@thecompliancemap.com
The Compliance Map Logo Watermark

Bevacizumab has been added to the list based on a formal requirement by the US Food and Drug Administration (FDA) that the chemical be identified or labeled as causing reproductive toxicity (developmental and female endpoints). 

Businesses are required to provide a clear and reasonable warning before knowingly and intentionally exposing anyone to Prop65 listed chemicals one year after being added to the list.

 

Get in touch to find out how we can help with your compliance requirements

EMEA: +44 (0) 1869 255758 /
US: +1 (800) 450 2403 /
Email: sales@thecompliancemap.com

AdobeStock_68767205-scaled.jpeg?w=1024&h=683&scale

EU Commission update: ELV Exemption

10th Mar 2023

Read article
ECHA-3.png?w=1024&h=576&scale

ECHA publishes report on enforcement with authorisation requirement of REACH

8th Mar 2023

Read article
AdobeStock_109824622-scaled.jpeg?w=1024&h=540&scale

UK Defra consults on POPs amendments

3rd Mar 2023

Read article